AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 41 of 43

42 Class of Recommendations and Level of Evidence Class of Recommendations and Level of Evidence * CLASS (STRENGTH) OF RECOMMENDATION CLASS 1 (STRONG) Benefit >>> Risk Suggested phrases for writing recommendations: ◼ Is recommended ◼ Is indicated/useful/effective/beneficial ◼ Should be performed/administered/other ◼ Comparative-Effectiveness Phrases † : ◦ Treatment/strategy A is recommended/indicated in preference to treatment B ◦ Treatment A should be chosen over treatment B CLASS 2a (MODERATE) Benefit >> Risk Suggested phrases for writing recommendations: ◼ Is reasonable ◼ Can be useful/effective/beneficial ◼ Comparative-Effectiveness Phrases † : ◦ Treatment/strategy A is probably recommended/indicated in preference to treatment B ◦ It is reasonable to choose treatment A over treatment B CLASS 2b (WEAK) Benefit ≥ Risk Suggested phrases for writing recommendations: ◼ May/might be reasonable ◼ May/might be considered ◼ Usefulness/effectiveness is unknown/unclear/uncertain or not well-established CLASS 3: No Benefit (MODERATE) (Generally, LOE A or B use only) Benefit = Risk Suggested phrases for writing recommendations: ◼ Is not recommended ◼ Is not indicated/useful/effective/beneficial ◼ Should not be performed/administered/other CLASS 3: Harm (STRONG) Risk > Benefit Suggested phrases for writing recommendations: ◼ Potentially harmful ◼ Causes harm ◼ Associated with excess morbidity/mortality ◼ Should not be performed/administered/other

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024